Filing Details

Accession Number:
0001209191-19-016013
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-04 19:24:54
Reporting Period:
2019-03-01
Accepted Time:
2019-03-04 19:24:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM Surgical & Medical Instruments & Apparatus (3841) 204327508
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1582970 Susan Morrison C/O Tandem Diabetes Care, Inc.,
11075 Roselle Street
San Diego CA 92121
Evp & Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-01 50,000 $2.59 53,745 No 4 M Direct
Common Stock Acquisiton 2019-03-01 4,597 $9.00 58,342 No 4 M Direct
Common Stock Acquisiton 2019-03-01 4,121 $11.06 62,463 No 4 M Direct
Common Stock Acquisiton 2019-03-01 1,282 $11.06 63,745 No 4 M Direct
Common Stock Disposition 2019-03-01 34,646 $67.35 29,099 No 4 S Direct
Common Stock Disposition 2019-03-01 25,354 $68.39 3,745 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2019-03-01 50,000 $0.00 50,000 $2.59
Common Stock Stock Option Disposition 2019-03-01 4,597 $0.00 4,597 $9.00
Common Stock Stock Option Disposition 2019-03-01 4,121 $0.00 4,121 $11.06
Common Stock Stock Option Disposition 2019-03-01 1,282 $0.00 1,282 $11.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,000 2027-12-01 No 4 M Direct
5,903 2027-05-17 No 4 M Direct
0 2023-04-23 No 4 M Direct
4,145 2023-04-23 No 4 M Direct
Footnotes
  1. The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2018, in multiple transactions at prices ranging from $67.00 to $67.99.
  2. The price reported reflects the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2018, in multiple transactions at prices ranging from $68.00 to $68.89.
  3. Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter
  4. Twenty five percent (25%) of the underlying shares subject to the option vested on 05/17/2018, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter
  5. The date of the option was 4/23/2013. All shares subject to the option vest in 24 equal monthly installments commencing on 4/23/2013.